Trial intelligence / Profile preview

TLIP Block with Liposomal Bupivacaine in Spinal Surgery

NCT04865211Phase 2Unknown

Sponsor
Cooper University Health Care
Start
Apr 2021
Primary completion
Feb 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of bupivacaine in postoperative pain, sponsored by Cooper University Health Care. Status: unknown.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04865211.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04865211.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call